VP

Vysali Ponnuru

Active Director Director DIN 10122691
DIN 10122691 First appointment Apr 2023 Primary industry Biotechnology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Vysali Ponnuru

Data last updated:

Vysali Ponnuru is a Director at Kemgen Biologics Private Limited (since 2023). The company operates in Biotechnology. Kemgen Biologics Private Limited reported revenue of ₹2.76 Cr (FY 2025).

DIN 10122691
Primary Designation Director
Industry Biotechnology
First Appointment 19 Apr 2023
Oldest Company Age 3 yrs
Largest company Kemgen Biologics Private Limited · ₹2.76 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kemgen Biologics Private Limited U46497TS2023PTC172099
Director19 Apr 20232023₹2.76 Cr (FY 2025)Active

Board colleagues of Vysali Ponnuru

NameDINCompanyDesignation
Ranjith Talluri10122692Kemgen Biologics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kemgen Biologics Private Limited
Premium access

Shareholding and investment profile for Vysali Ponnuru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vysali Ponnuru

Vysali Ponnuru currently holds 1 directorship: Kemgen Biologics Private Limited (Director, since 19 Apr 2023, revenue ₹2.76 Cr (FY 2025)).

Vysali Ponnuru was first appointed on 19 Apr 2023 as Director at Kemgen Biologics Private Limited.

The current boards of Vysali Ponnuru's companies include Ranjith Talluri (Kemgen Biologics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available